Provided by Tiger Trade Technology Pte. Ltd.

Invesco Nasdaq Biotechnology ETF

34.75
+0.38001.11%
Volume:100.22K
Turnover:3.46M
Market Cap:107.73M
PE:- -
High:34.80
Open:34.53
Low:34.07
Close:34.37
52wk High:36.84
52wk Low:25.00
Shares:3.10M
Float Shares:3.10M
Volume Ratio:1.32
T/O Rate:3.23%
Dividend:0.39
Dividend Rate:1.13%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Yahong Meditech's APL-2501 Doses First Patient in Phase I Study for Advanced Solid Tumors

Stock News
·
Sep 22

Sino Biopharmaceutical Stock Slips 1.4% in Hong Kong, Underperforms Competitors

Dow Jones
·
Sep 22

Orient Securities: Innovative Drugs Achieve Multi-Path Breakthroughs as Domestic Innovation Redefines Treatment Standards

Stock News
·
Sep 22

Moderna Inc. Stock Climbs 12.3%, Outperforms Peers

Dow Jones
·
Sep 22

Drug Innovation and Property Sectors Rally Together! Hong Kong Stock Connect Innovation Drug ETF's Underlying Index Spikes Up to 6.15% Intraday! Real Estate Surges for a Second Straight Day, Vanke A and Greenland Holdings Notch Consecutive Limit-Ups!

Deep News
·
Sep 21

Vertex Pharmaceuticals Incorporated : Leerink Partners Resumes Coverage with Outperform Rating; Target Price $594

THOMSON REUTERS
·
Sep 21

Fund Manager Cites AI Drug Development Momentum and Export Growth as Key Drivers for Pharmaceutical Sector Opportunities

Deep News
·
Sep 21

Jiangsu Hengrui Pharmaceuticals Secures Clinical Trial Approval for SHR-4595 Injection

Stock News
·
Sep 21

ETF Market Wrap for September 21: Policy Tailwinds and Clearer Outbound Channels Lift Innovative Drug Funds, While Crypto ETFs Surge Throughout the Day

Stock News
·
Sep 21

Hong Kong Equities Close Higher | Hang Seng Index Regains 25,000 Mark, Innovative Drug Shares Rally Broadly, SBP Group Tops Blue-Chip Gainers

Stock News
·
Sep 21

Sino Biopharmaceutical Stock Rises 8.2% in Hong Kong, Outperforms Competitors

Dow Jones
·
Sep 21

Market Shock: A-Share Leader and "Meme Stock" Both Plunge Dramatically

Deep News
·
Sep 21

Kexing Biopharm's GB20 Injection Receives Clinical Trial Approval From Regulators

Stock News
·
Sep 21

Anke Biotechnology Advances Novel Drug Candidate as Clinical Trial Application Gains Regulatory Acceptance

Stock News
·
Sep 21

Citi Highlights Policy Boost for Innovative Drugs and Medical Devices, Names Key Sector Picks

Stock News
·
Sep 21

Innovative Drug Sector Heats Up: Spotlight on Pure-Play R&D Developers

Deep News
·
Sep 21

Correction to Vertex Material Listing Article on Sept. 17

Dow Jones
·
Sep 21

Innovative Drug Stocks Surge Across the Board in Morning Session, with Keymed Bio-B and Akeso Both Climbing Over 9%

Deep News
·
Sep 21

Hong Kong Stock Movers | SBP Group Surges Over 6% as Management Reaffirms Annual Revenue Target, with Newly Approved Innovative Drugs Set to Drive Sustained Sales Growth

Stock News
·
Sep 21

Shanghai Shen Lian Biomedical's UB-221 Meets Primary Goal in Phase II Urticaria Trial

Stock News
·
Sep 20